Using data generated from patients and mice with genetic mutation for the disorder Usher syndrome, researchers from the University of…
Home »
Radiation therapy reprograms heart muscle cells to younger state
New research from Washington University School of Medicine in St. Louis suggests that radiation therapy can reprogram heart muscle cells…
Light therapy helps burn injuries heal faster by triggering growth protein
Light therapy may accelerate the healing of burns, according to a University at Buffalo-led study. The research, published in Scientific…
Study supports gene therapy as a promising treatment for soft bone disease
A preclinical study led by scientists at Sanford Burnham Prebys has established that AAV8-TNAP-D10—a gene therapy that replaces a key…
Paranoia therapy app SlowMo helps people ‘slow down’ and manage their fears
A new clinical trial from King’s College London’s Institute of Psychiatry, Psychology, & Neuroscience, in collaboration with Oxford University, Oxford…
Cellular benefits of gene therapy seen decades after treatment
An international collaboration between Great Ormond Street Hospital, the UCL GOS Institute for Child Health and Harvard Medical School has…
Antisense oligonucleotides as a feasible therapy to treat MECP2 duplication syndrome
Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To…
Study finds combination therapy suppresses pancreatic tumor growth in mice
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral…
Q&A: Y-90 therapy offers many benefits in treatment of liver cancer
Credit: CC0 Public Domain My father has had chronic liver disease. Recently, he was diagnosed with liver cancer. His doctor…
Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization
TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered…